These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 24750050)

  • 1. Management of the acute painful crisis in sickle cell disease- a re-evaluation of the use of opioids in adult patients.
    Telfer P; Bahal N; Lo A; Challands J
    Br J Haematol; 2014 Jul; 166(2):157-64. PubMed ID: 24750050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of a low-dose ketamine-midazolam regimen in the management of severe painful crisis in patients with sickle cell disease.
    Tawfic QA; Faris AS; Kausalya R
    J Pain Symptom Manage; 2014 Feb; 47(2):334-40. PubMed ID: 23856095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID; Woodward M; Reed GW
    Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of human recombinant hyaluronidase-enhanced subcutaneous hydration and opioid administration for sickle cell disease acute pain episodes.
    Sandoval M; Coleman P; Govani R; Siddiqui S; Todd KH
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):10-8. PubMed ID: 23527666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal diamorphine for acute sickle cell pain.
    Telfer P; Criddle J; Sandell J; Davies F; Morrison I; Challands J
    Arch Dis Child; 2009 Dec; 94(12):979-80. PubMed ID: 19321506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient pain clinic and intranasal fentanyl to improve sickle cell disease outcomes.
    Myrick R; Blakemore S; Waite E; Pernell B; Madan-Swain A; Hilliard L; Lebensburger J
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28648. PubMed ID: 32798305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial.
    Barrett MJ; Cronin J; Murphy A; McCoy S; Hayden J; an Fhailí S; Grant T; Wakai A; McMahon C; Walsh S; O'Sullivan R
    Trials; 2012 May; 13():74. PubMed ID: 22647439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid treatment for acute and chronic pain in patients with sickle cell disease.
    Carroll CP
    Neurosci Lett; 2020 Jan; 714():134534. PubMed ID: 31593753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
    De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
    Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature.
    Uprety D; Baber A; Foy M
    Ann Hematol; 2014 May; 93(5):769-71. PubMed ID: 24232306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute pain in adolescents and young adults with sickle cell disease: Delayed and increased opioid dosing following transition to adult care.
    Stehouwer N; Edge P; Katie Park B; Piccone C; Little J
    Am J Hematol; 2017 Apr; 92(4):E40-E42. PubMed ID: 28066934
    [No Abstract]   [Full Text] [Related]  

  • 13. The association between timely opioid administration and hospitalization in children with sickle cell disease presenting to the emergency department in acute pain.
    Muslu CS; Kopetsky M; Nimmer M; Visotcky A; Fraser R; Brousseau DC
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28268. PubMed ID: 32614150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of painful crisis in sickle cell disease.
    Wright J; Ahmedzai SH
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):97-106. PubMed ID: 20440206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
    van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
    Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral morphine protocol for sickle cell crisis pain.
    Conti C; Tso E; Browne B
    Md Med J; 1996 Jan; 45(1):33-5. PubMed ID: 8569458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Quality of Care for Sickle Cell Patients in the Pediatric Emergency Department.
    Lin SM; Strouse JJ; Whiteman LN; Anders J; Stewart RW
    Pediatr Emerg Care; 2016 Jan; 32(1):14-6. PubMed ID: 25834959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Mobile Health Apps and Wearable Technology to Assess Changes and Predict Pain During Treatment of Acute Pain in Sickle Cell Disease: Feasibility Study.
    Johnson A; Yang F; Gollarahalli S; Banerjee T; Abrams D; Jonassaint J; Jonassaint C; Shah N
    JMIR Mhealth Uhealth; 2019 Dec; 7(12):e13671. PubMed ID: 31789599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
    Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
    Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of sex disparities in opioid use among ED patients with sickle cell disease, 2006-2015.
    Wilson TT; Chou SC; Becker S; Schuur JD; Beaudoin F
    Am J Emerg Med; 2021 Dec; 50():597-601. PubMed ID: 34592567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.